SUMMARY Sputum, nasal swabs, and throat swabs were obtained from 22 children aged between 5 and 15 years during 72 attacks of wheezy bronchitis. A virus, most commonly a rhinovirus, was isolated in 49% of all episodes and in 64% of 22 severe episodes requiring treatment with corticosteroids; the isolation rate was higher early in the illness than later. Virus was recovered more often from sputum than from the nose or throat, suggesting that viral replication occurs freely in the lower respiratory tract: the cytological findings in sputum were compatible with an inflammatory response to viral infection. Pathogenic bacteria appeared to play a minor role compared with viruses, and routine antibiotic treatment was probably of little value in most cases. The significance of the results is discussed in relation to the pathogenesis of childhood wheezy bronchitis.
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Wheezy bronchitis of childhood may be defined as an acute illness usually preceded by upper respiratory symptoms and characterised by cough and variable degrees of wheezing, breathlessness, and mucus expectoration. On auscultation high-pitched wheeze is audible over most parts of the chest in addition to medium crepitations or rhonchi. Various terms such as 'asthmatic bronchitis', 'exacerbations of asthma', or 'bronchitis with bronchospasm' have been used to describe this illness. Several studies have established that during these episodes common respiratory viruses can be isolated from the upper respiratory tract (McIntosh et al., 1973; Minor et al., 1974; Horn et al., 1975; Mitchell et al., 1976) . Horn and Gregg (1973) and Horn et al. (1979) noted that certain children experience recurrent episodes of wheezy bronchitis and it seems clear that undetermined constitutional factors must influence the individual child's response to infection with common respiratory viruses. The pathogenic mechanisms underlying the cough, bronchoconstriction, and excess lower respiratory secretion that characterise this condition are unknown. It is possible either that the lower respiratory symptoms are a remote response to viral infection in the upper respiratory MARY E. C. HORN, 6 Genoa Avenue, London SW15 6DY MRC Common Cold Unit, Harvard Hospital, Salisbury SYLVIA E. REED, member of scientific staff Department of Microbiology, Brompton Hospital, London P. TAYLOR, chief medical laboratory scientific officer tract, or that they are a consequence of viral invasion of the bronchial mucosa.
We now describe a study designed to provide further evidence on this point. Sputum collected from children during attacks of wheezy bronchitis was examined in parallel with nasal and throat swabs using virological, bacteriological, and cytological techniques. all had a history of recurrent wheezy bronchitis and were among those previously investigated by Horn et al. (1975) . The number of episodes investigated per child ranged from one to 15. 19 of the 22 children wheezed on exercise, on exposure to inhaled least one of 14 inhaled allergens used in skin prick tests. These children were defined as atopic and the remaining 5 as nonatopic; 3 of the nonatopic children were known to wheeze only during attacks of wheezy bronchitis. A family history of asthma or allergic rhinitis was present in 12 atopic children and 5 nonatopic ones; the remaining 5 children had no such family history but were atopic on prick testing.
Episodes were classified retrospectively according to severity on the basis of airflow obstruction and the need to give corticosteroids, judged clinically. Airflow obstruction was measured by the fall in peak expiratory flow (PEF) rate, expressed as a percentage of the predicted PEF for height (Godfrey et al., 1970) . Episodes were classified as severe if treatment with corticosteroids was required for control or if the fall in PEF was at least 60%; moderate episodes were those which did not require corticosteroids and in which PEF fell by 40-59%; mild episodes were those in which the PEF fell by less than 40 %.
Appropriate bronchodilator or corticosteroid treatment was prescribed during the acute phase of the illness until prophylaxis with an oral bronchodilator and sodium cromoglycate or beclomethasone dipropionate aerosol could be resumed. Physiotherapy was an integral part of treatment and sputum samples were obtained by encouraging coughing during postural drainage and percussion.
As controls, 31 nasal and throat swabs collected from 17 children between acute attacks were also examined virologically, but control sputum samples could not be obtained.
The first sputum samples, nasal swabs, and throat swabs examined in each episode were collected at the child's first attendance, within 5 days of onset of respiratory symptoms, and before prescribing antibiotics or corticosteroids. Whenever possible a second nasal swab and sputum sample were obtained later in the illness, generally within 5 days of the first. If bacterial infection was thought likely on clinical grounds, penicillin, co-trimoxazole, or ampicillin (in order of frequency) was prescribed when the child first attended the clinic. One of these was prescribed at the second visit, after second samples had been collected, if the first samples had shown Streptococcus pyogenes in the throat or if there had been any pathogenic bacteria in the sputum and the clinical condition still warranted treatment.
Specimens for virological examination were kept chilled in transport medium and delivered to the laboratory within 4 hours. Throat swabs transported in Stewart's medium and sputum samples were examined bacteriologically, and the sputum was also examined cytologically.
Laboratory methods. The techniques for isolating viruses and Mycoplasma pneumoniae were as previously described (Horn et al., 1975) , except that MRC-5 human embryo lung fibroblasts were substituted for WI-38 cells which were no longer obtainable. After inoculation into standard cultures, the remainder of each specimen was stored at -700C and later cultured in rhinovirus-sensitive HeLa cells (Strizova et al., 1974) . Rhinoviruses were characterised by their typical cytopathic effect (cpe) and by their acid lability, but were not serotyped. No attempt was made to quantitate rhinovirus by titration, but the relative amount of virus present in the various types of specimens was assessed roughly by noting the day of development of rhinovirus cpe in the culture and calculating the means for nasal swabs and sputum samples. Organ cultures or other special techniques for isolation of coronaviruses were not used.
Throat swabs were cultured on blood agar and MacConkey agar incubated aerobically at 370C. Sputum was homogenised with pancreatin, shaken, and similarly cultured undiluted, and at a dilution of 10-4. Isolations of Streptococcus pneumoniae and Haemophilus influenzae were considered significant if the organisms were detected at a dilution of 10-4: Staphylococcus aureus and S. pyogenes in any numbers were considered significant. Sputum smears were stained with haematoxylin and carbol chromotrope 2R. The whole area of each specimen was examined by a single observer, and the prevalence of leucocytes, bronchial epithelial cells, and macrophages was estimated on an arbitrary scale 1+ to 3 +. Eosinophils were assessed as an approximated percentage of the total cellular content: an arbitrary figure of at least 25 % eosinophilia was considered abnormal, as were bronchial epithelial cells or macrophages scored as 1+ or more and leucocytes as 2 + or more.
Results 72 episodes of wheezy bronchitis were studied, of which 18 were classified as mild, 24 as moderate, and 30 as severe. Upper respiratory symptoms were present in all but one moderately severe episode. Rhinorrhoea was present in 71 episodes, pharyngitis in 39, otitis media in 2, sinusitis in 2, pyrexia in 11, headache in 8, and myalgia in 2. Sputum samples were obtained at the first attendance in all but 2 episodes in which severe bronchospasm prevented expectoration; in these 2, sputum was obtained at the second attendance. In a few episodes nasal or throat swabs could not be obtained. (Figure) . 29 (41 %) isolates were obtained from 70 first sputum samples, 15 (23%) from 64 first nasal swabs, and 14 (22%) from 64 throat swabs. The overall isolation rate from first sputum samples was therefore significantly higher than from the first nasal or throat swabs (P<0 -05, x2 test) . The mean day of development of rhinovirus cpe in HeLa cells was 3 -9 days for first sputum samples and 4 6 days for first nasal swabs, and in MRC-5 cells the corresponding figures were 5.1 and 8 0 days, indicating that the sputum probably contained more virus than the nasal swabs. The second samples, taken later in the illness, gave fewer isolates than the first, but again sputum showed more isolates than the nose. In only 3 episodes were second samples positive when first samples had been negative.
Only one of the 31 control swabs from the upper respiratory tract contained virus.
Bacteriology. 28 (39%) of the 72 episodes showed significant bacterial isolations but, in 15 of these, the isolations were from throat swabs; only 3 sputum samples contained the same organism as was found in the throat swab. Only 12 (17%) of 70 first sputum samples gave significant bacterial isolations (Table 2) , and the episodes from which these samples were obtained were not distinguishable by any particular clinical feature. The bacteria isolated from sputum in 6 virus-positive episodes Antibacterial agents were prescribed at the time of the first visit in 30 episodes but the cultures subsequently showed that bacterial infection had been present in only 9 of these episodes, 5 of the relevant first sputum samples being positive, and 7 of the throat swabs. No initial antibacterial therapy was given in 42 episodes, and only one second sample from these episodes contained bacteria (S. aureus) which had not been present in the first sample. Both first and second sputum samples were examined bacteriologically in 50 episodes of which 22 were treated with antibiotics at the time of the first visit and 28 were not. The bacterial isolation rate from first sputum samples was 14% in both the treated and the untreated group. In the second samples the rates fell in both groups, to 5 and 7 % respectively.
Cytology. The cells classified as macrophages contained foamy and particulate material and were considered by the cytologist to be alveolar in origin. The relative frequency of the various cell types appeared to be little influenced by the agent isolated (Table 3) and there was no significant correlation between any of the cytological findings and severity. Bronchial epithelial cells in second sputum samples were more common in 'bacteria-positive' than in 'bacteria-negative' episodes, but numbers were small and the differences not significant. Both leucocytosis and eosinophilia graded as significant were less common in second samples than in first, and the decrease in eosinophils occurred both in the presence and absence of corticosteroid treatment. In 48 episodes both first and second sputum samples were examined cytologically. In 21 such episodes initially treated with antibiotics, 81 % of first samples showed leucocytosis compared with 33 % of second samples (and this difference was significant, P<0 01, x2 test). In 27 episodes not treated with antibiotics the rates in first and second samples were 74 and 52% respectively (P>0 05, x2 test). *Defined in Methods, tvirus recovered from one or more of the specimens originating in the episode, tsignificant isolation of bacteria from either first or second sputum specimen from the episode.
group.bmj.com on June 21, 2017 -Published by http://adc.bmj.com/ Downloaded from Atopy. 14 episodes in the 5 nonatopic children were compared with 58 in the 17 atopic children. Significant eosinophilia in sputum was less common in the nonatopic children (43% of 14 episodes) than in the atopic group (78% of 58 episodes); the virus isolation rate was higher in the nonatopic (71 % of 14 episodes) than in the atopic children (43 % of 58 episodes). Both of these differences were significant (P <0 * 05, X2 test) although the statistical comparison was somewhat unsatisfactory as one atopic child contributed 9 episodes and one, who was nonatopic, contributed 15. The individual virus isolation rates in these 2 children were 7 (78 %) of 9 episodes in the nonatopic child and 6 (40%) of 15 episodes in the atopic child. The serum immunoglobulin A of each of these children was at the lower limit of the normal range for his age.
Discussion
Eadie et al. (1966) , Stenhouse (1967) , and Stott et al. (1968) found that rhinoviruses could be isolated from sputum of bronchitic adults, sometimes in high titre. Lambert and Stern (1972) cultured sputum and nasal and throat swabs from two asthmatic subjects, one of whom was a child, and recovered virus in 5 of 11 exacerbations. In the present study of wheezy bronchitis of childhood a virus was isolated from 49 % of episodes, and the sputum samples collected within 5 days of onset of symptoms gave a virus isolation rate of 41 %. These figures are probably an underestimate of the true incidence of viral infection as our techniques may have failed to detect some rhinovirus strains, which are particularly difficult to cultivate, as well as coronaviruses. The latter are known to be important in this condition (McIntosh et al., 1973) .
In previous studies, Horn et al. (1975, 1979) showed that rhinoviruses were the agents most often isolated from the upper respiratory tract during attacks of wheezy bronchitis; in the present study these viruses were found even more commonly in sputum, especially in severe episodes. Although the volume of sputum cultured for virus was probably greater than the volume of nasal secretions, the frequency of isolation of rhinovirus from sputum and the speed with which the cpe developed in the cultures strongly suggested that more virus was present in the lower than in the upper respiratory tract and that its detection in sputum was not simply due to contamination with upper respiratory secretions. As in earlier studies (Horn et al., 1975 (Horn et al., , 1979 Fridy et al. (1974) , Blair et al. (1976), and Hall et al. (1976) all showed minor abnormalities of peripheral airways function in normal adults with colds. The abnormality of the child who develops wheezy bronchitis during virus infection may therefore be associated not so much with the presence of virus in the lower respiratory tract as with its excessive replication there and the effect of this on his already increased liability to bronchoconstriction. This view is compatible with the findings of Empey et al. (1976) , who showed that the bronchoconstrictor response to histamine in normal subjects with colds was greater than in those without. These authors suggested that the response of the asthmatic, whose airways epithelial receptors are already sensitised, is an exaggeration of the normal.
Allergic factors may clearly also be relevant to the aetiology of childhood wheezy bronchitis; many of the patients are atopic and the present study shows that viral infection is often associated with sputum eosinophilia. A link between mechanisms of allergy and viral infection, at least in atopic subjects, has been given by Ida et al. (1977) 
